Medicine & Life Sciences
11-beta-Hydroxysteroid Dehydrogenases
11%
2-(1-(5-(cyclohexylcarbamoyl)-6-propylsulfanylpyridin-2-yl)-3-piperidyl)acetic acid
20%
Angioplasty
11%
Angiotensin Receptor Antagonists
12%
Angiotensin-Converting Enzyme Inhibitors
10%
Blood Pressure
14%
Botulinum Toxins
14%
Child
12%
Chlorthalidone
12%
Chronic Renal Insufficiency
31%
Confidence Intervals
21%
Cost-Benefit Analysis
28%
Dopamine Agonists
24%
Exercise
12%
Feasibility Studies
14%
Glucocorticoids
11%
Health Care Outcome Assessment
15%
Interferons
16%
Kidney
11%
Language Therapy
35%
Levodopa
28%
Melanoma
20%
Meta-Analysis
32%
Migraine Disorders
12%
Monoamine Oxidase
15%
Monoamine Oxidase Inhibitors
23%
Nephrotic Syndrome
24%
Odds Ratio
11%
Parkinson Disease
100%
Patient Reported Outcome Measures
15%
Placebos
31%
Plasma Exchange
15%
Prednisolone
23%
propylene diquat
14%
Pseudotumor Cerebri
16%
Quality of Life
29%
Random Allocation
20%
Randomized Controlled Trials
90%
Recurrence
14%
Renal Artery Obstruction
15%
Respiratory Tract Infections
11%
Resuscitation
11%
Safety
19%
Speech Therapy
32%
Spironolactone
10%
Steroids
13%
Survival
11%
Systematic Reviews
10%
Therapeutics
30%
Vasculitis
21%